LYELL IMMUNOPHARMA IN
1.1500
08-أكتوبر-24 12:04:05
15 متأخرة بدقائق
الأسهم
+0.0200
+1.77%
نطاق اليوم
1.1200 - 1.1698
ISIN
N/A
المصدر
NASDAQ
-
04 أكتوبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire
-
Lyell Immunopharma Announces Participation in Goldman Sachs Cell Therapy Day
24 سبتمبر 2024 15:05:00 بحسب Nasdaq GlobeNewswire
-
Lyell Immunopharma Announces Participation in September Investor Conferences
28 أغسطس 2024 15:05:00 بحسب Nasdaq GlobeNewswire
-
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2024
07 أغسطس 2024 15:05:01 بحسب Nasdaq GlobeNewswire
-
26 يونيو 2024 06:00:00 بحسب Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference
03 يونيو 2024 15:05:00 بحسب Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in BofA Securities Health Care Conference
07 مايو 2024 15:05:00 بحسب Nasdaq GlobeNewswire
-
Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024
06 مايو 2024 07:00:01 بحسب Nasdaq GlobeNewswire
-
05 مارس 2024 15:30:00 بحسب Nasdaq GlobeNewswire
-
28 فبراير 2024 15:05:00 بحسب Nasdaq GlobeNewswire
-
Lyell Immunopharma Announces Participation in March Investor Conferences
26 فبراير 2024 15:05:00 بحسب Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in 42nd Annual J.P. Morgan Healthcare Conference
03 يناير 2024 15:05:00 بحسب Nasdaq GlobeNewswire
-
Lyell Immunopharma Receives FDA Orphan Drug Designation for LYL845 for the Treatment of Melanoma
09 نوفمبر 2023 15:05:00 بحسب Nasdaq GlobeNewswire
-
Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2023
07 نوفمبر 2023 15:05:00 بحسب Nasdaq GlobeNewswire
-
31 أكتوبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire
-
27 سبتمبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire
-
11 سبتمبر 2023 07:00:00 بحسب Nasdaq GlobeNewswire
-
Lyell Immunopharma to Participate in Upcoming Investor Conferences
31 أغسطس 2023 15:05:00 بحسب Nasdaq GlobeNewswire
-
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2023
08 أغسطس 2023 15:05:01 بحسب Nasdaq GlobeNewswire
-
Lyell Immunopharma Appoints Matthew Lang as Chief Business Officer
05 يوليو 2023 15:05:00 بحسب Nasdaq GlobeNewswire
- <<
- <
- 1
- >